Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Nasopharyngeal Carcinoma 2Glioma 2Glioblastoma 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Frailty 1Chordoma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Astrocytoma 1

Interventions

Gemcitabine 295Fluorouracil 82Oxaliplatin 81130-nm albumin-bound paclitaxel 68Capecitabine 60Leucovorin 56Albumin-Bound Paclitaxel 54Radiotherapy 51Irinotecan 44Taxes 37Cisplatin 36Erlotinib Hydrochloride 34Radiosurgery 33pembrolizumab 29Docetaxel 27S 1 (combination) 26Bevacizumab 23folfirinox 22Nivolumab 21Magnetic Resonance Spectroscopy 17Cyclophosphamide 17Cetuximab 17irinotecan sucrosofate 16Radiation 16Drug Therapy 15Surgical Procedures, Operative 14Specimen Handling 11Biopsy 11durvalumab 10Paclitaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Neoplasms × Protons × Clear all
NCT01494155 2021-02-02

Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
50 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡